These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 16723992)

  • 21. Increased p21-activated kinase-1 expression is associated with invasive potential in uveal melanoma.
    Pavey S; Zuidervaart W; van Nieuwpoort F; Packer L; Jager M; Gruis N; Hayward N
    Melanoma Res; 2006 Aug; 16(4):285-96. PubMed ID: 16845324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors.
    Faivre S; Djelloul S; Raymond E
    Semin Oncol; 2006 Aug; 33(4):407-20. PubMed ID: 16890796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The p21Rac/Cdc42-activated kinases (PAKs).
    Knaus UG; Bokoch GM
    Int J Biochem Cell Biol; 1998 Aug; 30(8):857-62. PubMed ID: 9744077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of serine/threonine kinases in T-cell activation.
    Matthews SA; Cantrell DA
    Curr Opin Immunol; 2006 Jun; 18(3):314-20. PubMed ID: 16603344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biosignaling of mammalian Ste20-related kinases.
    Ling P; Lu TJ; Yuan CJ; Lai MD
    Cell Signal; 2008 Jul; 20(7):1237-47. PubMed ID: 18255267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2-amino-N-{4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-phenyl} acetamide (OSU-03012), a celecoxib derivative, directly targets p21-activated kinase.
    Porchia LM; Guerra M; Wang YC; Zhang Y; Espinosa AV; Shinohara M; Kulp SK; Kirschner LS; Saji M; Chen CS; Ringel MD
    Mol Pharmacol; 2007 Nov; 72(5):1124-31. PubMed ID: 17673571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential role of p21 Activated Kinase 1 (PAK1) in the invasion and motility of oral cancer cells.
    Parvathy M; Sreeja S; Kumar R; Pillai MR
    BMC Cancer; 2016 May; 16 Suppl 1(Suppl 1):293. PubMed ID: 27229476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitors of p21-activated kinases (PAKs).
    Rudolph J; Crawford JJ; Hoeflich KP; Wang W
    J Med Chem; 2015 Jan; 58(1):111-29. PubMed ID: 25415869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stable expression of intracellular Notch suppresses v-Src-induced transformation in avian neural cells.
    Mateos S; Amarir S; Laugier D; Marx M; Calothy G
    Oncogene; 2007 May; 26(23):3338-51. PubMed ID: 17146440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sliding p21-activated kinase 1 to nucleus impacts tamoxifen sensitivity.
    Rayala SK; Kumar R
    Biomed Pharmacother; 2007 Aug; 61(7):408-11. PubMed ID: 17604944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. P21-activated protein kinase is overexpressed in hepatocellular carcinoma and enhances cancer metastasis involving c-Jun NH2-terminal kinase activation and paxillin phosphorylation.
    Ching YP; Leong VY; Lee MF; Xu HT; Jin DY; Ng IO
    Cancer Res; 2007 Apr; 67(8):3601-8. PubMed ID: 17440071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitors of signal transduction protein kinases as targets for cancer therapy.
    Mikalsen T; Gerits N; Moens U
    Biotechnol Annu Rev; 2006; 12():153-223. PubMed ID: 17045195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lim kinase regulates the development of olfactory and neuromuscular synapses.
    Ang LH; Chen W; Yao Y; Ozawa R; Tao E; Yonekura J; Uemura T; Keshishian H; Hing H
    Dev Biol; 2006 May; 293(1):178-90. PubMed ID: 16529736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p21-activated kinases and gastrointestinal cancer.
    He H; Baldwin GS
    Biochim Biophys Acta; 2013 Jan; 1833(1):33-9. PubMed ID: 23092728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Signal transduction by focal adhesion kinase in cancer.
    Zhao J; Guan JL
    Cancer Metastasis Rev; 2009 Jun; 28(1-2):35-49. PubMed ID: 19169797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Requirement of reversible caldesmon phosphorylation at P21-activated kinase-responsive sites for lamellipodia extensions during cell migration.
    Eppinga RD; Li Y; Lin JL; Mak AS; Lin JJ
    Cell Motil Cytoskeleton; 2006 Sep; 63(9):543-62. PubMed ID: 16800003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p21-activated kinase signaling in breast cancer.
    Gururaj AE; Rayala SK; Kumar R
    Breast Cancer Res; 2005; 7(1):5-12. PubMed ID: 15642175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of Rac1 in fibronectin-induced adhesion and motility of human corneal epithelial cells.
    Kimura K; Kawamoto K; Teranishi S; Nishida T
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4323-9. PubMed ID: 17003422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Host tissue invasion by Entamoeba histolytica is powered by motility and phagocytosis.
    Labruyère E; Guillén N
    Arch Med Res; 2006 Feb; 37(2):253-8. PubMed ID: 16380326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selenium regulates cyclooxygenase-2 and extracellular signal-regulated kinase signaling pathways by activating AMP-activated protein kinase in colon cancer cells.
    Hwang JT; Kim YM; Surh YJ; Baik HW; Lee SK; Ha J; Park OJ
    Cancer Res; 2006 Oct; 66(20):10057-63. PubMed ID: 17047069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.